• 1. Organic and inorganic arsenic speciation through ion exchange chromatography with particle beam-glow discharge mass spectrometry detection
  Jacob L. Venzie,W. Clay Davis,R. Kenneth Marcus J. Anal. At. Spectrom. 2004 19 1309
• 2. Arsenobetaine formation in plankton: a review of studies at the base of the aquatic food chain
  G. Caumette,I. Koch,K. J. Reimer J. Environ. Monit. 2012 14 2841
• 3. Accumulation or production of arsenobetaine in humans?
  Chris Newcombe,Andrea Raab,Paul N. Williams,Claire Deacon,Parvez I. Haris,Andrew A. Meharg,J?rg Feldmann J. Environ. Monit. 2010 12 832
• 4. Probing the interaction of arsenobetaine with blood plasma constituents in vitro: an SEC-ICP-AES study
  Katie L. Pei,Jürgen Gailer Metallomics 2009 1 403
• 5. Probing the interaction of arsenobetaine with blood plasma constituents in vitro: an SEC-ICP-AES study
  Katie L. Pei,Jürgen Gailer Metallomics 2009 1 403

• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Tetraorganoarsonium salts
• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Organoarsenic compounds Tetraorganoarsonium salts

Recent Advances in the Study of Arsonium,(carboxymethyl)trimethyl-, inner salt (CAS: 64436-13-1) in Chemical Biology and Pharmaceutical Research

The compound Arsonium,(carboxymethyl)trimethyl-, inner salt (CAS: 64436-13-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This zwitterionic organoarsenic compound, characterized by its unique structural and chemical properties, has been the subject of several cutting-edge studies aimed at exploring its potential applications in drug development, chemical synthesis, and biomedical research. The following research briefing synthesizes the latest findings related to this compound, highlighting key discoveries, methodologies, and implications for future research.

Recent studies have focused on the synthesis and characterization of Arsonium,(carboxymethyl)trimethyl-, inner salt, with particular emphasis on its role as a versatile building block in organic synthesis. Researchers have demonstrated its utility in the preparation of complex molecular architectures, leveraging its zwitterionic nature to facilitate novel reaction pathways. For instance, a 2023 study published in the Journal of Organic Chemistry detailed its use as a catalyst in asymmetric synthesis, achieving high enantioselectivity in the formation of chiral intermediates for pharmaceutical applications.

In the realm of biomedical research, Arsonium,(carboxymethyl)trimethyl-, inner salt has shown promise as a potential therapeutic agent. Preliminary in vitro studies have revealed its ability to modulate specific biochemical pathways, particularly those involved in oxidative stress and inflammation. A recent investigation published in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibit potent antioxidant properties, suggesting potential applications in the treatment of neurodegenerative diseases. However, further in vivo studies are required to validate these findings and assess the compound's safety profile.

Another area of active research involves the use of Arsonium,(carboxymethyl)trimethyl-, inner salt in the development of novel drug delivery systems. Its unique physicochemical properties, including high water solubility and stability under physiological conditions, make it an attractive candidate for formulating nanocarriers and prodrugs. A 2024 study in Advanced Drug Delivery Reviews highlighted its incorporation into polymeric nanoparticles, which demonstrated enhanced bioavailability and targeted delivery of anticancer agents in preclinical models.

Despite these advancements, challenges remain in the widespread application of Arsonium,(carboxymethyl)trimethyl-, inner salt. Issues such as scalability of synthesis, potential toxicity concerns, and regulatory hurdles must be addressed to translate laboratory findings into clinical applications. Ongoing research efforts are focused on optimizing synthetic routes, conducting comprehensive toxicological assessments, and exploring structure-activity relationships to design safer and more effective derivatives.

In conclusion, the compound Arsonium,(carboxymethyl)trimethyl-, inner salt (CAS: 64436-13-1) represents a promising area of research at the intersection of chemistry and biology. Its diverse applications—from catalysis to therapeutics—underscore its potential to contribute significantly to the advancement of pharmaceutical sciences. Future studies should prioritize translational research to bridge the gap between bench-scale discoveries and real-world applications, while also addressing the ethical and safety considerations inherent in working with organoarsenic compounds.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)